Diagnostics News and Research

RSS

Multi-fluid microRNA signals as markers of endometriosis

Researchers uncover distinct microRNA profiles in bodily fluids, offering insights into noninvasive diagnostic markers for endometriosis and its complexities.

27 Jan 2026

Prospera™ featured in landmark interventional study advancing lung transplant care

Natera, Inc., a global leader in cell-free DNA and precision medicine, today announced the publication of a new prospective clinical trial in Transplantation Direct. The study, which was conducted by The Ohio State University Wexner Medical Center (OSU-WMC), was initiated to explore whether donor-derived cell-free DNA (dd-cfDNA) surveillance, and specifically Prospera-guided monitoring, could reduce the number of invasive biopsies for patients following lung transplantation.

From Natera 27 Jan 2026

Physical behavior reveals aggressive cancer cells in a simple new approach

New study shows that aggressive cancer cells can be identified in a simple, new way; by how they physically behave, not just by their genes.

26 Jan 2026

Orphan noncoding RNAs define cancer identity and enable blood-based monitoring

We knew we had something interesting with T3p, a single small RNA found in breast cancer but absent from normal tissue.

24 Jan 2026

WHO Member States advance negotiations on the Pathogen Access and Benefit‑Sharing system

The World Health Organization (WHO) Member States this week advanced their negotiations on the Pathogen Access and Benefit‑Sharing (PABS) system in a resumed session of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement.

24 Jan 2026

Blood-based epigenetic signatures enable early risk assessment in prediabetes

Prediabetes is an extremely heterogeneous metabolic disorder. Scientists from several partner institutes of the German Center for Diabetes Research (DZD) have now used artificial intelligence (AI) to identify epigenetic markers that indicate an elevated risk of complications.

24 Jan 2026

Nearly half of adults now live with heart disease as obesity and diabetes surge

The 2026 American Heart Association Heart Disease and Stroke Statistics report shows that nearly half of adults are living with cardiovascular disease, with cardiometabolic risk factors projected to rise substantially by 2050. Despite progress in smoking reduction and cholesterol control, worsening obesity, diabetes, hypertension, sleep health, and persistent inequities threaten future cardiovascular health.

22 Jan 2026

See through the skin: New technology spots early heart disease warning signs

Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed "fast-RSOM", a new imaging technology that can capture detailed images of the smallest blood vessels directly through the skin – without the need for invasive procedures.

22 Jan 2026

Bedfont® Scientific Limited is pleased to support a major milestone to improve asthma care

Bedfont® Scientific Limited, a medical device manufacturer based in Kent, with over 49 years’ experience in the breath analysis industry, was pleased to support its UK distributor, Intermedical UK, in supplying the 3,000th NObreath® Fractional exhaled Nitric Oxide (FeNO) device in the UK.

From NObreath 22 Jan 2026

Rice’s SynthX Center leads interdisciplinary effort to tackle rare lymphatic disorders

Rice University's SynthX Center, directed by Han Xiao, has received an up to five-year, $18 million award from the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics and pHenotyping Technologies (LIGHT) program to develop innovative solutions for lymphatic diseases.

20 Jan 2026

Weill Cornell Medicine receives ARPA-H award to advance lymphatic disease diagnosis

Weill Cornell Medicine has received a $5.2 million, initial two-year award from the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics, and pHenotyping Technologies (LIGHT) program to develop a comprehensive and innovative approach to diagnosing lymphatic disease.

20 Jan 2026

Measles resurgence: Global Virus Network calls for urgent action

The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing research, collaboration, and pandemic preparedness, expresses deep concern regarding the ongoing resurgence of measles in the United States and around the globe.

20 Jan 2026

Atypical mutation offers clues to personalized pancreatic cancer treatment

A new study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene mutation behaves differently from other variants.

20 Jan 2026

How "old RNA" reshapes sperm metabolism

Increasing paternal age has been linked to elevated health risks for the next generation, including higher risks of obesity and stillbirth. But what drives this increased risk remains unknown.

20 Jan 2026

Plasma protein profiling can help detect cancer in patients with non-specific symptoms

A simple blood test can help detect cancer in patients with non-specific symptoms such as fatigue, pain or weight loss. This is according to a Swedish study from Karolinska Institutet, Danderyd Hospital and others, published in Nature Communications.

19 Jan 2026

Global Alzheimer’s Platform Foundation announces strategic collaboration and partnership with Spear Bio for the transformative Bio-Hermes-002 study

The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study.

From Spear Bio 18 Jan 2026

New noninvasive technique can quickly collect 3D images of the human body

In a proof-of-concept study funded by the National Institutes of Health, researchers from the Keck School of Medicine of USC and the California Institute of Technology (Caltech) have shown that an innovative, noninvasive technique can be used to quickly collect 3D images of the human body, from head to foot.

16 Jan 2026

Immune dysfunction persists after combined TB and HIV therapy

The immune system remains seriously out-of-whack – in an inflammatory state of overactivation and impaired functionality – following the international gold standard for treating people with latent tuberculosis (TB) and HIV, a team at Texas Biomedical Research Institute reports in Nature Communications.

14 Jan 2026

Novel liquid biopsy technology could advance cancer diagnostics and monitoring

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple workflow.

14 Jan 2026

Silent thief of sight: Rutgers Health experts highlight glaucoma risks, early detection

January is Glaucoma Awareness Month, prompting Rutgers Health experts to underscore the importance of early detection and public awareness.

14 Jan 2026

Diagnostics News and Research

Multi-fluid microRNA signals as markers of endometriosis

Prospera™ featured in landmark interventional study advancing lung transplant care

Physical behavior reveals aggressive cancer cells in a simple new approach

Orphan noncoding RNAs define cancer identity and enable blood-based monitoring

WHO Member States advance negotiations on the Pathogen Access and Benefit‑Sharing system

Blood-based epigenetic signatures enable early risk assessment in prediabetes

Nearly half of adults now live with heart disease as obesity and diabetes surge

See through the skin: New technology spots early heart disease warning signs

Bedfont® Scientific Limited is pleased to support a major milestone to improve asthma care

Rice’s SynthX Center leads interdisciplinary effort to tackle rare lymphatic disorders

Weill Cornell Medicine receives ARPA-H award to advance lymphatic disease diagnosis

Measles resurgence: Global Virus Network calls for urgent action

Atypical mutation offers clues to personalized pancreatic cancer treatment

How "old RNA" reshapes sperm metabolism

Plasma protein profiling can help detect cancer in patients with non-specific symptoms

Global Alzheimer’s Platform Foundation announces strategic collaboration and partnership with Spear Bio for the transformative Bio-Hermes-002 study

New noninvasive technique can quickly collect 3D images of the human body

Immune dysfunction persists after combined TB and HIV therapy

Novel liquid biopsy technology could advance cancer diagnostics and monitoring

Silent thief of sight: Rutgers Health experts highlight glaucoma risks, early detection

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News